×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 7: Track 3: eConsent: Permission to Adopt!
Session Chair(s)
Betsy Fallen, RN
Consultant
BAFallen Consulting LLC, United States
Informed consent is one of the biggest challenges facing clinical trials. The opportunity to digitize the IC and manage it electronically offers many advantages. The panel of key stakeholders will share their experiences and answer your questions.
Learning Objective : At the conclusion of this session, participants should be able to:- Recognize the challenges that drive adoption of eConsent.
- Identify the pros and cons for clinical sites to participate in a trial using eConsent
- Describe the lifecycle of the documentation of eConsent.
- Evaluate the ROI of implementing eConsent.
Speaker(s)
eConsent: An IRB’s Perspective
Sandra Sanford, MSN, RN
Advarra, United States
Director of Quality Control
Electronic Informed Consent Use in Phase I Clinical Research Units
Mark Gregorio, MSN
Pfizer, Inc., United States
The State of eConsent
Michael Tucker
Medidata, a Dassault Systèmes Company, United States